Abstract

1659P The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract B083: The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials
Christophe Massard ... Yohann Loriot
Cancer Research | VOL. 84
Christophe Massard, et. al.Christophe Massard ... Yohann Loriot
16 Jan 2024
Locally Advanced Non-Metastatic Pancreatic Cancer — Can We Do More?
D. Tait ... M.A. Hawkins
Clinical Oncology | VOL. 20
D. Tait, et. al.D. Tait ... M.A. Hawkins
09 Jul 2008
Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma
Shingo Kurahashi ... Seiichi Kato
Blood | VOL. 140
Shingo Kurahashi, et. al.Shingo Kurahashi ... Seiichi Kato
15 Nov 2022
The Use of Liquid Biopsies in Patients With NSCLC
Nitika Sharma ... Krish Bhadra
Oncology Times | VOL. 39
Nitika Sharma, et. al.Nitika Sharma ... Krish Bhadra
25 Nov 2017
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: “ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe”, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
VP2-2024: Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial
H Li ... E Song
Annals of Oncology | VOL. -
H Li, et. al.H Li ... E Song
01 May 2024
View more papers